CLGM
GILD icon

Capitolis Liquid Global Markets’s Gilead Sciences GILD Stock Holding History

Capitolis Liquid Global Markets’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.4M Buy
643,915
+1,915
+0.3% +$252K 0.35% 64
2026
Q1 		$89.5M Buy
642,000
+66,000
+11% +$9.24M 0.57% 34
2025
Q4 		$70.7M Buy
576,000
+212,000
+58% +$25.8M 0.42% 55
2025
Q3 		$40.4M Buy
+364,000
New +$41.4M 0.32% 59

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capitolis Liquid Global Markets's GILD Position: Q2 2026 in Review

Capitolis Liquid Global Markets increased its Gilead Sciences (GILD) stake by 0.3% in Q2 2026, buying an estimated $252K and bringing the position to 643,915 shares worth $81.4M. The position accounts for 0.35% of the portfolio, ranked #64.

Capitolis Liquid Global Markets first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $89.5M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Capitolis Liquid Global Markets held 643,915 shares of Gilead Sciences worth $81.4M as of Q2 2026.
  • Capitolis Liquid Global Markets bought 1,915 Gilead Sciences shares in Q2 2026, an estimated $252K.
  • Gilead Sciences made up 0.35% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #64 holding.
  • Capitolis Liquid Global Markets first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Capitolis Liquid Global Markets's Gilead Sciences position peaked at $89.5M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.